US0080642061
US0080642061
Jade Biosciences, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 915.17M EUR | 1.41B EUR | 693.31M EUR | 760.95M EUR |
Enterprise Value | 440.09M EUR | 1.31B EUR | 638.9M EUR | 673.24M EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -5.4x | -- | -- | -- |
Price to Sales | -- | -- | -- | -- |
Price to Book | 2.08x | 3.21x | 2.34x | 2.29x |
EV/Revenue | -- | -- | -- | -- |
EV/EBITDA | -2.67x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -- | -8.75% | -14.45% | -10% |